In acid medium, rhodamine B（RhB）, rhodamine S（RhS）, rhodamine 6G（RhG） and butyl rhodamine B（b-RhB） have a fluorescence peak at 580, 549, 553 and 580nm, respectively. BrO^-3 oxidizes excess I^- into I^-3 Rhodam...In acid medium, rhodamine B（RhB）, rhodamine S（RhS）, rhodamine 6G（RhG） and butyl rhodamine B（b-RhB） have a fluorescence peak at 580, 549, 553 and 580nm, respectively. BrO^-3 oxidizes excess I^- into I^-3 Rhodamine dyes combine I^-3 to form ion association nanoparticles, resulting in fluorescence quenching at 580, 549, 553 and 580 rim, respectively. The fluorescence quenching intensity is proportional to the concentration of BrO^-3 in the range of 0.020 4 - 0.710 μg/mL for RhB, 0.025 - 0. 512μg/mL for RhS, 0.025 - 0.260 μg/mL for RhG, 0.025 - 1.28μg/mL for b-RhB, respectively. In the four systems, RhB system has good stability and high sensitivity. Thus, a simple, sensitive fluorescence method was proposed for the determination of BrO^-3 in commercial bread additives and flours, with satisfactory results. The results of the fluorescence spectra and scan electron microscopy show that the formation of about 60 ran （RhB - I^-3） n association nanoparticles and the interface between the nanoparticles and solution are main factors that cause the fluorescence quenching.展开更多
Alcohol-associated liver disease(ALD)is a common chronic liver disease and major contributor to liver disease-related deaths worldwide.Despite its prevalence,there are few effective pharmacological options for the sev...Alcohol-associated liver disease(ALD)is a common chronic liver disease and major contributor to liver disease-related deaths worldwide.Despite its prevalence,there are few effective pharmacological options for the severe stages of this disease.While much pre-clinical research attention is paid to drug development in ALD,many of these experimental therapeutics have limitations such as poor pharmacokinetics,poor efficacy,or off-target side effects due to systemic administration.One means of addressing these limitations is through liver-targeted drug delivery,which can be accomplished with different platforms including liposomes,polymeric nanoparticles,exosomes,bacteria,and adenoassociated viruses,among others.These platforms allow drugs to target the liver passively or actively,thereby reducing systemic circulation and increasing the‘effective dose’in the liver.While many studies,some clinical,have applied targeted delivery systems to other liver diseases such as viral hepatitis or hepatocellular carcinoma,only few have investigated their efficacy in ALD.This review provides basic information on these liver-targeting drug delivery platforms,including their benefits and limitations,and summarizes the current research efforts to apply them to the treatment of ALD in rodent models.We also discuss gaps in knowledge in the field,which when addressed,may help to increase the efficacy of novel therapies and better translate them to humans.展开更多
A previous study by our group found that inhibition of nischarin promotes neurite outgrowth and neuronal regeneration in Neuro-2 a cells and primary cortical neurons.In recent years,more and more studies have shown th...A previous study by our group found that inhibition of nischarin promotes neurite outgrowth and neuronal regeneration in Neuro-2 a cells and primary cortical neurons.In recent years,more and more studies have shown that nanomaterials have good prospects in treatment of spinal cord injury.We proposed that small interfering RNA targeting nischarin（Nis-si RNA） delivered by polyethyleneimine-alginate（PEIALG） nanoparticles promoted motor function recovery in rats with spinal cord injury.Direct microinjection of 5 μL PEI-ALG/Nis-si RNA into the spinal cord lesion area of spinal cord injury rats was performed.From day 7 after surgery,Basso,Beattie and Bresnahan score was significantly higher in rats from the PEI-ALG/Nis-si RNA group compared with the spinal cord injury group and PEI-ALG/Control-si RNA group.On day 21 after injection,hematoxylin-eosin staining showed that the necrotic area was reduced in the PEI-ALG/Nis-si RNA group.Immunohistochemistry and western blot assay results confirmed successful inhibition of nischarin expression and increased protein expression of growth-associated protein-43 in the PEI-ALG/Nis-si RNA group.These findings suggest that a complex of PEI-ALG nanoparticles and Nis-si RNA effectively suppresses nischarin expression,induces expression of growth-associated protein-43,and accelerates motor function recovery after spinal cord injury.展开更多
Objective: To determine the changes in serum levels of inflammatory biomarkers and antioxidant levels among the knee osteoarthritis(OA) patients after treatment with Phyllanthus amarus(PP) by nanoparticle gel phonopho...Objective: To determine the changes in serum levels of inflammatory biomarkers and antioxidant levels among the knee osteoarthritis(OA) patients after treatment with Phyllanthus amarus(PP) by nanoparticle gel phonophoresis. Methods: This study was a randomized, double-blind, placebo-control, parallel-group, clinical trial involving 30 subjects with mild-to-moderate degree of knee OA. The patients were allocated to two groups using a computer-generated random numbers, and received conventional ultrasound therapy(control group, 15 cases) and PP(treatment group, 15 cases) once daily for 10 sessions. The pain was evaluated by visual analogue scale(VAS). Serum levels of tumor necrosis factor-α(TNF-α) were determined by enzyme-linked immunosorbnent assay(ELISA). Nitric oxide(NO) was determined by modified Griess reagent. The antioxidant effects, including superoxide dismutase(SOD) and total antioxidant capacity(TAC), were also measured by ELISA assay. Results: The VAS score was significantly decreased in the treatment group compared with the control group after treatment(P<0.01). The serum concentrations of TNF-α and NO were significantly reduced in the treatment group compared with the control group(P<0.01) after treatment. However, the serum concentrations of SOD and TAC in the treatment group were significantly higher after treatment compared with the control group(P<0.01). Conclusion: PP could alleviate knee pain and significantly reduce systemic antiinflammatory effects in knee OA patients.展开更多
三阴性乳腺癌(triple-negative breast cancer,TNBC)因缺乏明显的标志物及有效的靶向治疗,是乳腺癌亚型中侵袭性及病死率最高的恶性肿瘤。肿瘤微环境(tumor microenvironment,TME)是癌症的重要组成部分,而肿瘤相关巨噬细胞(tumor-associ...三阴性乳腺癌(triple-negative breast cancer,TNBC)因缺乏明显的标志物及有效的靶向治疗,是乳腺癌亚型中侵袭性及病死率最高的恶性肿瘤。肿瘤微环境(tumor microenvironment,TME)是癌症的重要组成部分,而肿瘤相关巨噬细胞(tumor-associated macrophages,TAMs)是TME中占比最高的免疫细胞。TAMs可以极化为抑制肿瘤的M1型和促进肿瘤的M2型TAMs,二者在一定条件下可以相互转化。M1型TAMs通过促进炎症和免疫反应发挥抗肿瘤活性。M2型TAMs通常表达高水平的细胞因子、生长因子和蛋白酶,支持其致癌功能。TAMs在TNBC中的作用机制正在被阐明。纳米药物载体的抗肿瘤作用可以促进M2型向M1型TAMs转化或直接靶向M2型TAMs从而杀伤癌细胞。未来靶向TAMs可能成为TNBC辅助治疗的重要策略。展开更多
文摘In acid medium, rhodamine B（RhB）, rhodamine S（RhS）, rhodamine 6G（RhG） and butyl rhodamine B（b-RhB） have a fluorescence peak at 580, 549, 553 and 580nm, respectively. BrO^-3 oxidizes excess I^- into I^-3 Rhodamine dyes combine I^-3 to form ion association nanoparticles, resulting in fluorescence quenching at 580, 549, 553 and 580 rim, respectively. The fluorescence quenching intensity is proportional to the concentration of BrO^-3 in the range of 0.020 4 - 0.710 μg/mL for RhB, 0.025 - 0. 512μg/mL for RhS, 0.025 - 0.260 μg/mL for RhG, 0.025 - 1.28μg/mL for b-RhB, respectively. In the four systems, RhB system has good stability and high sensitivity. Thus, a simple, sensitive fluorescence method was proposed for the determination of BrO^-3 in commercial bread additives and flours, with satisfactory results. The results of the fluorescence spectra and scan electron microscopy show that the formation of about 60 ran （RhB - I^-3） n association nanoparticles and the interface between the nanoparticles and solution are main factors that cause the fluorescence quenching.
基金Supported by National Institutes of Health,No. R01AA028905-01A1 (to Kirpich IA),No. 1F31AA028423-01A1 (to Warner JB),No. F32AA027950-01A1 (to Hardesty JE) and No. U01AA026934 (to McClain CJ)Jewish Heritage Fund for Excellence Research Enhancement Grant Program at the University of Louisville+1 种基金an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health,No. P20GM113226 (to McClain CJ)National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health,No. P50AA024337 (to McClain CJ)
文摘Alcohol-associated liver disease(ALD)is a common chronic liver disease and major contributor to liver disease-related deaths worldwide.Despite its prevalence,there are few effective pharmacological options for the severe stages of this disease.While much pre-clinical research attention is paid to drug development in ALD,many of these experimental therapeutics have limitations such as poor pharmacokinetics,poor efficacy,or off-target side effects due to systemic administration.One means of addressing these limitations is through liver-targeted drug delivery,which can be accomplished with different platforms including liposomes,polymeric nanoparticles,exosomes,bacteria,and adenoassociated viruses,among others.These platforms allow drugs to target the liver passively or actively,thereby reducing systemic circulation and increasing the‘effective dose’in the liver.While many studies,some clinical,have applied targeted delivery systems to other liver diseases such as viral hepatitis or hepatocellular carcinoma,only few have investigated their efficacy in ALD.This review provides basic information on these liver-targeting drug delivery platforms,including their benefits and limitations,and summarizes the current research efforts to apply them to the treatment of ALD in rodent models.We also discuss gaps in knowledge in the field,which when addressed,may help to increase the efficacy of novel therapies and better translate them to humans.
基金supported by the Natural Science Foundation of Zhejiang Province of China,No.LY15H250001 and LY14H090002the National Natural Science Foundation of China,No.81000535 and 81402872+1 种基金the Medical Science and Technology Project Foundation of Zhejiang Province of China,No.2014KYA166the Science and Technology Innovation Talents Development Plan Foundation for High School Students in Zhejiang Province of China,No.2014R401186
文摘A previous study by our group found that inhibition of nischarin promotes neurite outgrowth and neuronal regeneration in Neuro-2 a cells and primary cortical neurons.In recent years,more and more studies have shown that nanomaterials have good prospects in treatment of spinal cord injury.We proposed that small interfering RNA targeting nischarin（Nis-si RNA） delivered by polyethyleneimine-alginate（PEIALG） nanoparticles promoted motor function recovery in rats with spinal cord injury.Direct microinjection of 5 μL PEI-ALG/Nis-si RNA into the spinal cord lesion area of spinal cord injury rats was performed.From day 7 after surgery,Basso,Beattie and Bresnahan score was significantly higher in rats from the PEI-ALG/Nis-si RNA group compared with the spinal cord injury group and PEI-ALG/Control-si RNA group.On day 21 after injection,hematoxylin-eosin staining showed that the necrotic area was reduced in the PEI-ALG/Nis-si RNA group.Immunohistochemistry and western blot assay results confirmed successful inhibition of nischarin expression and increased protein expression of growth-associated protein-43 in the PEI-ALG/Nis-si RNA group.These findings suggest that a complex of PEI-ALG nanoparticles and Nis-si RNA effectively suppresses nischarin expression,induces expression of growth-associated protein-43,and accelerates motor function recovery after spinal cord injury.
基金Supported by CMU Junior Research Fellowship Programthe Faculty of Associated Medical Sciences,Chiang Mai University,Thailand(No.8/2560)
文摘Objective: To determine the changes in serum levels of inflammatory biomarkers and antioxidant levels among the knee osteoarthritis(OA) patients after treatment with Phyllanthus amarus(PP) by nanoparticle gel phonophoresis. Methods: This study was a randomized, double-blind, placebo-control, parallel-group, clinical trial involving 30 subjects with mild-to-moderate degree of knee OA. The patients were allocated to two groups using a computer-generated random numbers, and received conventional ultrasound therapy(control group, 15 cases) and PP(treatment group, 15 cases) once daily for 10 sessions. The pain was evaluated by visual analogue scale(VAS). Serum levels of tumor necrosis factor-α(TNF-α) were determined by enzyme-linked immunosorbnent assay(ELISA). Nitric oxide(NO) was determined by modified Griess reagent. The antioxidant effects, including superoxide dismutase(SOD) and total antioxidant capacity(TAC), were also measured by ELISA assay. Results: The VAS score was significantly decreased in the treatment group compared with the control group after treatment(P<0.01). The serum concentrations of TNF-α and NO were significantly reduced in the treatment group compared with the control group(P<0.01) after treatment. However, the serum concentrations of SOD and TAC in the treatment group were significantly higher after treatment compared with the control group(P<0.01). Conclusion: PP could alleviate knee pain and significantly reduce systemic antiinflammatory effects in knee OA patients.
文摘三阴性乳腺癌(triple-negative breast cancer,TNBC)因缺乏明显的标志物及有效的靶向治疗,是乳腺癌亚型中侵袭性及病死率最高的恶性肿瘤。肿瘤微环境(tumor microenvironment,TME)是癌症的重要组成部分,而肿瘤相关巨噬细胞(tumor-associated macrophages,TAMs)是TME中占比最高的免疫细胞。TAMs可以极化为抑制肿瘤的M1型和促进肿瘤的M2型TAMs,二者在一定条件下可以相互转化。M1型TAMs通过促进炎症和免疫反应发挥抗肿瘤活性。M2型TAMs通常表达高水平的细胞因子、生长因子和蛋白酶,支持其致癌功能。TAMs在TNBC中的作用机制正在被阐明。纳米药物载体的抗肿瘤作用可以促进M2型向M1型TAMs转化或直接靶向M2型TAMs从而杀伤癌细胞。未来靶向TAMs可能成为TNBC辅助治疗的重要策略。
